Thomas J. Wargovich

2.1k total citations · 1 hit paper
26 papers, 1.6k citations indexed

About

Thomas J. Wargovich is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Thomas J. Wargovich has authored 26 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 9 papers in Physiology and 7 papers in Molecular Biology. Recurrent topics in Thomas J. Wargovich's work include Nitric Oxide and Endothelin Effects (9 papers), Blood Pressure and Hypertension Studies (6 papers) and Cardiac Imaging and Diagnostics (5 papers). Thomas J. Wargovich is often cited by papers focused on Nitric Oxide and Endothelin Effects (9 papers), Blood Pressure and Hypertension Studies (6 papers) and Cardiac Imaging and Diagnostics (5 papers). Thomas J. Wargovich collaborates with scholars based in United States, Canada and Switzerland. Thomas J. Wargovich's co-authors include Carl J. Pepine, Harry Haber, Blair J. O’Neill, Bertram Pitt, Carlos Macaya, Harald Mudra, Ronald G. Carere, Andrew C. G. Uprichard, G.B. John Mancini and Michael Klibaner and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Medicine.

In The Last Decade

Thomas J. Wargovich

25 papers receiving 1.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease

1996 837 citations G.B. John Mancini, Carlos Macaya et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas J. Wargovich United States	15	1.0k	404	334	308	230	26	1.6k
Osamu Hirashima Japan	15	948 0.9×	461 1.1×	401 1.2×	245 0.8×	151 0.7×	20	1.7k
Nobutaka Hirai Japan	17	895 0.9×	310 0.8×	411 1.2×	227 0.7×	186 0.8×	28	1.6k
Yuji Miyao Japan	24	1.3k 1.3×	326 0.8×	392 1.2×	538 1.7×	392 1.7×	57	2.5k
Toshiyuki Matsumura Japan	18	910 0.9×	206 0.5×	200 0.6×	375 1.2×	218 0.9×	35	1.5k
R. F. Bing United Kingdom	20	565 0.6×	256 0.6×	443 1.3×	172 0.6×	357 1.6×	91	1.6k
Lawrence T. McGrath United Kingdom	15	614 0.6×	542 1.3×	244 0.7×	186 0.6×	207 0.9×	27	1.5k
Naoshi Arakawa Japan	19	1.1k 1.1×	348 0.9×	140 0.4×	210 0.7×	202 0.9×	41	1.6k
Motoo Tsushima Japan	28	898 0.9×	236 0.6×	554 1.7×	771 2.5×	288 1.3×	86	2.3k
Yuliy Y. Chirkov Australia	24	1.2k 1.2×	485 1.2×	204 0.6×	239 0.8×	246 1.1×	71	1.7k
Hiromi Tasaki Japan	21	610 0.6×	570 1.4×	166 0.5×	395 1.3×	359 1.6×	67	1.5k

Countries citing papers authored by Thomas J. Wargovich

Since Specialization

Citations

This map shows the geographic impact of Thomas J. Wargovich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Wargovich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Wargovich more than expected).

Fields of papers citing papers by Thomas J. Wargovich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Wargovich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Wargovich. The network helps show where Thomas J. Wargovich may publish in the future.

Co-authorship network of co-authors of Thomas J. Wargovich

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Wargovich. A scholar is included among the top collaborators of Thomas J. Wargovich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Wargovich. Thomas J. Wargovich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Feldman, Robert L., Thomas J. Wargovich, & John A. Bittl. (1999). No-touch technique for reducing aortic wall trauma during renal artery stenting. Catheterization and Cardiovascular Interventions. 46(2). 245–248. 51 indexed citations

Grant, Maria B., Thomas J. Wargovich, David M. Bush, et al.. (1999). Expression of IGF-1, IGF-1 receptor and TGF-β following balloon angioplasty in atherosclerotic and normal rabbit iliac arteries: An immunocytochemical study. Regulatory Peptides. 79(1). 47–53. 28 indexed citations

Wargovich, Thomas J., Blair J. O’Neill, G.B.John Mancini, et al.. (1997). Effects of Quinapril on Coronary Blood Flow in Coronary Artery Disease Patients With Endothelial Dysfunction. The American Journal of Cardiology. 80(12). 1594–1597. 44 indexed citations

Mancini, G.B. John, Carlos Macaya, Blair J. O’Neill, et al.. (1996). Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease. Circulation. 94(3). 258–265. 837 indexed citations breakdown →

Klibaner, Michael, et al.. (1996). Angiotensin converting enzyme inhibition, with quinapril, improves endothelial vasomotor dysfunction in patients with coronary artery disease: The TREND study (trial on reversing endothelial dysfunction). Journal of the American College of Cardiology. 27(2). 19–19. 2 indexed citations

Wargovich, Thomas J., E. Ann Ellis, Roy Tarnuzzer, et al.. (1996). Expression of IGF-I, IGF-I receptor and IGF binding proteins -1, -2, -3, -4 and -5 in human atherectomy specimens. Regulatory Peptides. 67(3). 137–144. 49 indexed citations

Kerensky, Richard A., et al.. (1996). Lysis of intravascular thrombus prior to coronary stenting using the dispatch infusion catheter. Catheterization and Cardiovascular Diagnosis. 38(4). 410–414. 2 indexed citations

Wargovich, Thomas J., et al.. (1996). Is coronary microvascular endothelial dysfunction reversible? Six month effects of quinapril on coronary flow. Journal of the American College of Cardiology. 27(2). 130–130. 2 indexed citations

Savage, Michael P., John S. Douglas, David L. Fischman, et al.. (1995). 710-2 Coronary Stents Versus Balloon Angioplasty for Aorto-Coronary Saphenous Vein Bypass Graft Disease: Interim Results of a Randomized Trial. Journal of the American College of Cardiology. 25(2). 79A–79A. 7 indexed citations

10.

El‐Tamimi, Hassan, Michael Mansour, Carl J. Pepine, Thomas J. Wargovich, & Henry Chen. (1995). Circadian Variation in Coronary Tone in Patients With Stable Angina. Circulation. 92(11). 3201–3205. 45 indexed citations

11.

Grant, Maria B., Thomas J. Wargovich, E. Ann Ellis, et al.. (1994). Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. A potential treatment for restenosis?. Circulation. 89(4). 1511–1517. 132 indexed citations

12.

El‐Tamimi, Hassan, et al.. (1994). Usefulness of endogenous and exogenous nitric oxide to identify degrees of endothelial dysfunction in patients with stable angina pectoris. The American Journal of Cardiology. 74(6). 600–603. 4 indexed citations

13.

Wargovich, Thomas J., et al.. (1993). Repeat balloon occlusion of a pulmonary arteriovenous fistula following cavopulmonary anastomosis in tetralogy of fallot. Catheterization and Cardiovascular Diagnosis. 28(3). 238–240. 1 indexed citations

14.

Ellis, E. Ann, Maria B. Grant, & Thomas J. Wargovich. (1993). Cytochemical localization of free-radical-derived oxidants in human coronary atherectomy plaques. Proceedings annual meeting Electron Microscopy Society of America. 51. 318–319.

15.

Wargovich, Thomas J., R. Glen Macdonald, James A. Hill, et al.. (1988). Myocardial metabolic and hemodynamic effects of dichloroacetate in coronary artery disease. The American Journal of Cardiology. 61(1). 65–70. 85 indexed citations

16.

Mehta, J, Larry M. Lopez, Daniel Lawson, Thomas J. Wargovich, & Lisa L. Williams. (1988). Dietary supplementation with omega-3 polyunsaturated fatty acids in patients with stable coronary heart disease. The American Journal of Medicine. 84(1). 45–52. 90 indexed citations

17.

Wargovich, Thomas J., J Mehta, Wilmer W. Nichols, et al.. (1987). Reduction in myocardial neutrophil accumulation and infarct size following administration of thromboxane inhibitor U-63,557A. American Heart Journal. 114(5). 1078–1085. 29 indexed citations

18.

Mehta, Jawahar L., Thomas J. Wargovich, & Wilmer W. Nichols. (1986). Biphasic effects of platelet-activating factor on coronary blood flow in anesthetized dog. Prostaglandins Leukotrienes and Medicine. 21(1). 87–95. 23 indexed citations

19.

Wargovich, Thomas J., Jawahar L. Mehta, Wilmer W. Nichols, Carl J. Pepine, & C Conti. (1985). Reduction in blood flow in normal and narrowed coronary arteries of dogs by leukotriene C4. Journal of the American College of Cardiology. 6(5). 1047–1051. 24 indexed citations

20.

Wargovich, Thomas J., et al.. (1985). Peptide 6A, a fibrin(ogen) degradation product, increases coronary blood flow. American Journal of Physiology-Heart and Circulatory Physiology. 249(3). H457–H462. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact